July 2023

Viral hepatitis can be eliminated through collaborative approach – ET HealthWorld

Mumbai: Viral hepatitis is a major global health problem, affecting an estimated 354 million people worldwide. The most common types of viral hepatitis are Hepatitis A, B, and C. Hepatitis A is typically a mild illness that resolves on its own, but Hepatitis B and C can cause chronic liver disease, liver cancer, and death.

Viral hepatitis can be eliminated through collaborative approach – ET HealthWorld Read More »

First patient dosed in Immutep’s soft tissue sarcoma trial

The phase 2 study involves company’s eftilagimod alpha therapy Immutep – a company focused on developing novel LAG-3 immunotherapies for cancer and autoimmune diseases – has announced that the first patient has been dosed in its EFTISARC-NEO trial. The pivotal phase 2 study involves the company’s eftilagimod alpha (efti) therapy – a

First patient dosed in Immutep’s soft tissue sarcoma trial Read More »

Scroll to Top